An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease
Crohn's Disease
About this trial
This is an interventional treatment trial for Crohn's Disease focused on measuring Dehydroepiandrosterone, DHEA, Crohn's disease, C-reactive protein, CRP, Crohn's Disease Activity Index, CDAI, Inflammatory Bowel Disease Questionnaire, IBDQ
Eligibility Criteria
Inclusion Criteria: Diagnosis of Crohn's disease made at least 3 months prior to study entry. C-reactive protein above the upper limit of normal. Currently have moderately active Crohn's disease. Exclusion Criteria: Women who are pregnant or lactating or of childbearing potential. History of colostomy, ileostomy, intestinal resection resulting in short bowel syndrome or symptomatic strictures. Symptoms (abdominal pain, vomiting) and radiographic evidence of mechanical bowel obstruction within the previous 6 months. Fistulizing disease. Positive stool culture for enteric pathogens and/or C. difficile toxin. History of significant disease.
Sites / Locations
- Clinical Research Associates
- Advanced Clinical Research Institute
- Sharp Rees-Stealy Medical Group
- Clinical Research of West Florida
- Borland-Groover Clinic
- Atlanta Gastroenterology Associates
- Northwest Gastroenterologists
- The University of Chicago Hospital
- University of Louisville, Department of Internal Medicine
- Ochsner Clinic Foundation
- Maryland Clinical Trials
- Jason Bodzin, MD
- AGA Clinical Research Associates
- New York Center for Clinical Research
- Charlotte Gastroenterology and Hepatology
- Consultants for Clinical Research
- The Cleveland Clinic Foundation, Dept. of Gastroenterology
- Penn State Milton S. Hershey Medical Center
- Allegheny Center for Digestive Health
- The Medical University of South Carolina
- Nashville Medical Research Institute
- Atilla Ertan, MD
- Mountain West Gastroenterology
- SMG Reseach
- University of Vermont College of Medicine / Fletcher Allen Health Care
- McGuire DVAMC GI (111N)
- University of Washington Medical Center, Department of Gastroenterology
- Tacoma Digestive Disease Research Center
- Wisconsin Center for Advanced Research
- GILDR Group
- Gastrointestinal Research Institute
- Alan Cockeram, MD
- IBD Clinical and Research Centre
- Queen Elizabeth II Health Sciences Centre
- Doug Hemphill, MD
- Credit Valley Digestive Disease Group
- Philip Hassard, MD
- Saskatoon Medical Specialists